Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: August 18, 2006
Last updated: September 15, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2002
  Primary Completion Date: September 2002 (Final data collection date for primary outcome measure)